CytoSorbents Corporation (CTSO) News, Price and Chart - FAWS

Your browser has either disabled or does not support javascript. Javascript is required for full website experience.

Tue May 11th, 2021

- 19:30
  CytoSorbents, Progenity Receive Funding For Product DevelopmentBenzinga

Wed May 5th, 2021

- 03:18
  EarningsAnalysisCytoSorbents Corporation (CTSO) CEO Phillip Chan on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha

Tue April 27th, 2021

- 17:55
  Press ReleasesCytoSorbents to Report Q1 2021 Operating and Financial ResultsPR Newswire

Mon March 29th, 2021

- 11:08
  Press ReleasesCytoSorbents Announces Lease of New Global Headquarters in Princeton, New JerseyPR Newswire

Tue March 16th, 2021

- 19:15
  Press ReleasesCytoSorbents Announces Filing of an Investigational Device Exemption (IDE) for U.S. Trial on Ticagrelor Removal During Cardiothoracic SurgeryPR Newswire

Fri March 12th, 2021

- 12:00
  Press ReleasesCytoSorbents to Present at the Oppenheimer 31st Annual Healthcare ConferencePR Newswire

Wed March 10th, 2021

- 06:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  EarningsAnalysisCytosorbents' (CTSO) CEO Phillip Chan on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha

Tue March 9th, 2021

- 21:15
  Press ReleasesCytoSorbents Announces 2020 Financial and Operational ResultsPR Newswire

Mon March 1st, 2021

- 23:00
  Press ReleasesCytoSorbents to Report Fiscal 2020 Operating and Financial ResultsPR Newswire

Wed February 24th, 2021

- 12:08
  Press ReleasesCytoSorbents to Present at the Cowen 41st Annual Health Care ConferencePR Newswire

Thu February 18th, 2021

- 12:08
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  90
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents 2021: Leadership and Growth in the "New Normal"PR Newswire

Tue February 16th, 2021

- 12:08
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents to Present at the 10th Annual SVB Leerink Global Healthcare ConferencePR Newswire

Thu January 21st, 2021

- 12:08
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Appoints David D. Cox, PhD, MBA as Vice President - Global Regulatory AffairsPR Newswire

Tue January 19th, 2021

- 12:08
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Announces Approval of CytoSorb® in Korea in Collaboration with Partner Fresenius Medical CarePR Newswire

Tue January 12th, 2021

- 11:58
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Reports Preliminary Fourth Quarter and Full Year 2020 RevenuePR Newswire

Mon January 11th, 2021

- 11:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Appoints James Komsa as Vice President - U.S. Sales and MarketingPR Newswire

Sat January 9th, 2021

- 08:03
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisMeridian Bioscience: Benefiting From A Prolonged PandemicSeeking Alpha

Thu December 17th, 2020

- 12:08
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Promotes Dr. Christian Steiner to Executive Vice President of Sales and MarketingPR Newswire

Wed December 2nd, 2020

- 12:08
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Launches International Campaign to Raise $100,000 for the Global Humanitarian Organization, CAREPR Newswire

Wed November 25th, 2020

- 12:08
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Highlights Largest Published Case Series To Date Using CytoSorb in Critically Ill COVID-19 PatientsPR Newswire

Fri November 20th, 2020

- 19:14
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  AnalysisCytosorbents: Concentration Risk With Covid-19 OverexposureSeeking Alpha

Thu November 12th, 2020

- 07:00
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents to Present at the Jefferies Virtual London Healthcare ConferencePR Newswire

Thu November 5th, 2020

- 03:28
  EarningsAnalysisCytosorbents Corporation (CTSO) CEO Phillip Chan on Q3 2020 Results - Earnings Call TranscriptSeeking Alpha

Wed November 4th, 2020

- 21:15
  ^{0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9
  0
  1
  2
  3
  4
  5
  6
  7
  8
  9}
  Press ReleasesCytoSorbents Reports Record Third Quarter 2020 Financial ResultsPR Newswire

Wed October 21st, 2020

- 11:08
  Press ReleasesCytoSorbents to Report Q3 2020 Operating and Financial ResultsPR Newswire

Fri October 9th, 2020

- 11:08
  Press ReleasesThe U.S. Department of Defense Awards $1.1 Million to CytoSorbents to Optimize Development of HemoDefend-BGA™ for Life-saving Universal PlasmaPR Newswire

Tue September 8th, 2020

- 11:08
  Press ReleasesCytoSorbents Announces the "CytoSorb Therapy in COVID-19 ICU Patients" (CTC) Registry Is Actively EnrollingPR Newswire

Mon August 17th, 2020

- 11:08
  Press ReleasesCytoSorbents Partners with InvoSurg and Surgical Partners to Commercialize CytoSorb® in the U.S. Northeast, Mid-Atlantic, and Florida under FDA Emergency Use Authorization for COVID-19PR Newswire

Tue August 11th, 2020

- 13:25
  AnalysisRelief Therapeutics Discovers A Promising COVID-19 KillerSeeking Alpha

Wed August 5th, 2020

- 13:01
  EarningsAnalysisCytosorbents Corp (CTSO) Q2 2020 Earnings Call TranscriptThe Motley Fool
- 04:24
  EarningsAnalysisCytosorbents Corporation (CTSO) CEO Phillip Chan on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha

Tue August 4th, 2020

- 20:15
  Press ReleasesCytoSorbents Reports Record Second Quarter 2020 Financial ResultsPR Newswire

Mon August 3rd, 2020

- 11:00
  Press ReleasesCytoSorbents Achieves Milestone of More than 100,000 CytoSorb Treatments Delivered Cumulatively To DatePR Newswire

Fri July 31st, 2020

- 11:08
  Press ReleasesCytoSorbents Awarded $4.4 Million Contract by the U.S. Department of Defense to Complete HemoDefend-BGA Adsorber Preclinical DevelopmentPR Newswire

Tue July 28th, 2020

- 11:08
  Press ReleasesCytoSorbents Announces the REFRESH 2-AKI Trial Data Monitoring Committee Has Recommended Study Resumption Following Favorable Review of Safety DataPR Newswire
- 10:00
  Press ReleasesCytoSorbents to Report Q2 2020 Operating and Financial ResultsPR Newswire

Wed July 22nd, 2020

- 16:31
  AnalysisWhy CytoSorbents Is Soaring 12% TodayThe Motley Fool
- 11:22
  Press ReleasesCytoSorbents Corporation Announces Pricing of $50 Million Public Offering of Common StockPR Newswire

Tue July 21st, 2020

- 19:48
  AnalysisWhy CytoSorbents Stock Got Clobbered TodayThe Motley Fool

Mon July 20th, 2020

- 20:51
  Press ReleasesCytoSorbents Provides Preliminary Q2 2020 Financial Results and Corporate UpdatePR Newswire

SPY$395.63-3.6%

QQQ$315.85-1.1%

DOW$64.14-5.8%

--

SPY$395.63-3.6%

QQQ$315.85-1.1%

DOW$64.14-5.8%

--

About Developer Contact